Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Predictive and Prognostic Markers for Lung Cancer With Metastases

NCT02301858 is registered in ClinicalTrials.gov with Janna Berg as lead sponsor.

NCT NCT02301858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02301858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Predictive and Prognostic Markers for Lung Cancer With Metastases
Lead sponsor
Janna Berg
Phase
Not applicable
Overall status
Unknown status
Start date
December 31, 2013
Completion date
December 31, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, metastases, primary tumor